Wang Tingting is a Professor and Doctoral Supervisor at Nanjing University School of Medicine. She received her joint doctoral training at the Hillman Cancer Center, University of Pittsburgh, USA, and completed her postdoctoral research at the University of Texas MD Anderson Cancer Center. Currently, she serves as Vice Dean of Nanjing University School of Medicine, Standing Committee Member of the Gastrointestinal Oncology Society of the Chinese Anti-Cancer Association, and Vice Chairman of the Jiangsu Society for Immunology. Professor Wang Tingting focuses on basic research into the immune regulation of intestinal fungi and the pathogenesis and progression of colorectal cancer. Centering on the shared pathological mechanisms underlying the development of colitis and colorectal cancer, she conducts research on the functions and intervention strategies of Dectin-3/CARD9-mediated intestinal fungal dysbiosis in the initiation and progression of colitis and colorectal cancer, and carries out relevant studies on molecular mechanisms and therapeutics, which are of important clinical significance. She has published a total of 53 SCI papers, among which 34 have been published as first or corresponding author (including co-first and co-corresponding authors) in prestigious journals such as Immunity, The EMBO Journal, Science Advances, Advanced Functional Materials, Gut Microbes, and Oncogene. Her research achievements are internationally leading and have attracted extensive attention and high recognition from peer experts at home and abroad. Her SCI papers have been cited 1,213 times, with an H-index of 32. She was selected as one of the Highly Cited Researchers in the World for 2020 and 2021. Additionally, she has presided over 4 General Programs funded by the National Natural Science Foundation of China (all in the field of intestinal microecology and tumorigenesis) and other scientific research projects.